CRIS Current Research Information System

GIUNCHI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.887
NA - Nord America 3.882
EU - Europa 2.669
AF - Africa 329
Continente sconosciuto - Info sul continente non disponibili 247
SA - Sud America 226
OC - Oceania 8
Totale 12.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.785
CN - Cina 1.289
SG - Singapore 1.271
VN - Vietnam 1.254
IT - Italia 748
DE - Germania 392
GB - Regno Unito 349
HK - Hong Kong 332
SE - Svezia 269
KR - Corea 213
IN - India 181
NL - Olanda 174
BR - Brasile 163
FR - Francia 152
FI - Finlandia 113
RU - Federazione Russa 110
CI - Costa d'Avorio 89
IE - Irlanda 89
JP - Giappone 68
TG - Togo 62
CA - Canada 57
ZA - Sudafrica 57
CH - Svizzera 56
SC - Seychelles 54
JO - Giordania 43
BD - Bangladesh 35
TH - Thailandia 34
UA - Ucraina 34
BG - Bulgaria 33
EE - Estonia 31
NG - Nigeria 29
PH - Filippine 28
AR - Argentina 27
AT - Austria 25
ID - Indonesia 25
PK - Pakistan 23
IQ - Iraq 22
BE - Belgio 21
PL - Polonia 21
MX - Messico 20
TW - Taiwan 14
ES - Italia 13
EG - Egitto 12
TR - Turchia 11
CL - Cile 9
IR - Iran 8
JM - Giamaica 7
MA - Marocco 7
PY - Paraguay 7
SA - Arabia Saudita 7
LT - Lituania 6
VE - Venezuela 6
AU - Australia 5
AZ - Azerbaigian 5
DZ - Algeria 5
EC - Ecuador 5
KE - Kenya 5
TN - Tunisia 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
LB - Libano 4
PT - Portogallo 4
AL - Albania 3
BO - Bolivia 3
CO - Colombia 3
CR - Costa Rica 3
GE - Georgia 3
GR - Grecia 3
HR - Croazia 3
MY - Malesia 3
NP - Nepal 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
EU - Europa 2
HU - Ungheria 2
LU - Lussemburgo 2
RO - Romania 2
UY - Uruguay 2
CY - Cipro 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
LI - Liechtenstein 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NA - Namibia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PG - Papua Nuova Guinea 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 12.001
Salva come PNG Salva come JPEG
Città #
Singapore 910
Ashburn 553
Hefei 431
Hong Kong 311
Ho Chi Minh City 283
Southend 278
Hanoi 273
San Jose 271
Chandler 254
Fairfield 228
Bologna 207
Seoul 201
Beijing 151
Santa Clara 150
Houston 110
Council Bluffs 109
Seattle 105
Los Angeles 101
Wilmington 99
Woodbridge 90
Abidjan 89
Ann Arbor 89
Dublin 89
Boardman 87
Dallas 85
Princeton 82
Helsinki 79
Cambridge 76
Milan 75
Dong Ket 66
Lomé 62
Lauterbourg 61
New York 59
Tokyo 52
Munich 50
Bern 49
Amman 42
Bengaluru 40
São Paulo 38
Da Nang 35
Sofia 33
Bremen 32
Frankfurt am Main 32
Redondo Beach 31
Nanjing 30
Westminster 30
Abeokuta 29
Berlin 29
Buffalo 29
Krefeld 29
Haiphong 28
Padova 26
Turin 25
Johannesburg 23
Chicago 22
Brussels 21
Changsha 21
Jinan 21
Tongling 21
Falkenstein 20
Biên Hòa 19
London 19
Rome 19
Bangkok 17
Guangzhou 17
Montreal 17
Nuremberg 17
Redmond 17
Saint Petersburg 17
Turku 17
Lappeenranta 16
Jakarta 15
Shanghai 15
The Dalles 15
Tianjin 15
Warsaw 14
Amsterdam 13
Paris 13
San Diego 13
Thái Nguyên 13
Toronto 13
Naples 12
Redwood City 12
San Francisco 12
Vienna 12
Hangzhou 11
Hải Dương 11
Orem 11
Rimini 11
Shenyang 11
Stockholm 11
Xi'an 11
Atlanta 10
Florence 10
Medford 10
Thái Bình 10
Boston 9
Hebei 9
Kyiv 9
Quận Bình Thạnh 9
Totale 7.484
Salva come PNG Salva come JPEG
Nome #
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 272
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) 245
Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging 239
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 236
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 235
Effectiveness of Radiomic ZOT Features in the Automated Discrimination of Oncocytoma from Clear Cell Renal Cancer 228
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma 225
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 217
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 216
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations 211
18F-FACBC PET/CT FOR NODAL STAGING IN HIGH RISK PROSTATE CANCER: PRELIMINARY DIAGNOSTIC ACCURACY ANALYSIS 210
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection 204
Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge 203
Fibrotic Adhesive Toxic-fat (F.A.T.): the association of fibrotic and adhesive perirenal fat with peri-operative outcomes of robot-assisted par tial nephrectomy (RAPN) 203
[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial 202
Incremento dell’attività di RM multiparametrica della prostata: esperienza di un centro a elevato volume di attività 201
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes 200
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and midterm follow-up 200
The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy 200
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? 196
A case of prolonged cholestatic hepatitis induced by azithromycin in a young woman 195
Beyond multiparametric MRI and towards radiomics to detect prostate cancer: A machine learning model to predict clinically significant lesions 194
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: Correlations with cholangiocarcinoma aggressiveness 190
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates 190
Compa rison of 18F-fluciclovine PET/CT with 11 C-Choline PET/CT for nodal staging in prostate cancer: a prospective study 188
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis 180
Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance 180
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis. 178
Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers. 174
POSSIAMO INCLUDERE NELLA SORVEGLIANZA ATTIVA PER NEOPLASIA PROSTATICA, PAZIENTI CON CGS 3+4 IN UN UNICO PRELIEVO BIOPTICO? RISULTATI A MEDIO TERMINE DI UN SINGOLO CENTRO DOPO REVISIONE ISTOLOGICA SISTEMATICA DEI PRELIEVI BIOPTICI E DEI REPERTI OPERATORI 170
Mutations of NOTCH Genes as an Alternative Mechanism to Activate mTOR pathway in Low-grade Oncocytic Tumor (LOT) of the Kidney 169
Frozen section analysis of unusual small testicular tumor masses: report of 3 cases 169
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial 169
The role of MRI in the detection of local recurrence: Added value of multiparametric approach and Signal Intensity/Time Curve analysis 167
PI-RADS version 2.1 for the evaluation of transition zone lesions: a practical guide for radiologists 166
Incidence, etiology, histologic findings, and courses of thoracic inflammatory aortopathies 164
Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer 163
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 160
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study 160
Beyond multiparametric MRI and towards radiomics to detect prostate cancer: A machine learning model to predict clinically significant lesions 159
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy 156
Primary liver sarcomatous carcinoma: report of two cases and review of the literature. 156
Perineural invasion and risk of lethal prostate cancer 154
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 153
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 152
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge 150
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 150
Revised Gleason Grading System Is a Better Predictor of Indolent Prostate Cancer at the Time of Diagnosis: Retrospective Clinical-Pathological Study on Matched Biopsy and Radical Prostatectomy Specimens. 148
MULTIPLE RENAL ONCOCYTIC TUMORS: HISTOLOGICAL, IMMUNOHISTOCHEMICAL AND CYTO-GENETICAL COMPARATIVE ANALYSIS 146
The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis. 146
Site-specific concordance of targeted and systematic biopsy cores at the index lesion on multiparametric magnetic resonance: can we spare the double-tap? 143
The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 143
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients 143
Abstracts from USCAP 2020: Genitourinary Pathology (860-1046) HPV Status and World Health Organization 2016 Classification of Penile Squamous Cell Carcinoma and Penile Intraepithelial Neoplasia: 206 Cases from a Single, Contemporary, Western Cohort of Patients with Emphasis on the “Discordant Cases" 133
Similarities and differences between clear cell tubulo-papillary and conventional clear cell renal cell carcinoma: A comparative phenotypical and mutational analysis 133
Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience 133
Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters 128
Emerging Molecular Technologies in Genitourinary Tumors 128
Diagnostic Accuracy of 11C-Choline PET/CT in Preoperative Lymph Node Staging of Bladder Cancer: A Systematic Comparison With Contrast-Enhanced CT and Histologic Findings. 126
Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones 126
Role of multiparametric magnetic resonance and ultrasound-guided/MR fusion biopsy in patients with low-risk prostate cancer suitable for active surveillance 123
Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review 121
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging 118
The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors 111
SOX2 and PRAME in the "reprogramming" of seminoma cells 110
Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort 108
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors 108
First case of bilateral, synchronous anaplastic variant of spermatocytic seminoma treated with radical orchifunicolectomy as single approach: Case report and review of the literature 104
Case Report: Pulmonary Actinomyces Infection Mimics Lung Cancer on [68Ga]Ga-FAPI PET/CT 101
Interobserver agreement of PD-L1 (SP263) assessment in advanced NSCLC on cytological smears and histological samples 91
null 84
Role of PD-L1 assessment in advanced NSCLC: does it still matter? 84
Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing 80
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab 78
null 73
The new classification of renal cell carcinoma: what is the clinical issue? 44
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 35
Totale 12.248
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022780 0 18 30 72 60 35 42 70 38 68 219 128
2022/20231.250 90 168 70 131 116 89 50 61 220 47 89 119
2023/2024687 66 65 44 53 42 95 50 61 108 35 33 35
2024/20252.312 133 244 187 137 240 131 177 96 53 224 211 479
2025/20265.273 633 636 479 431 520 202 601 119 959 368 175 150
2026/2027269 119 150 0 0 0 0 0 0 0 0 0 0
Totale 12.248